Free Trial
NASDAQ:LFMD

LifeMD (LFMD) Stock Price, News & Analysis

$4.83
+0.15 (+3.21%)
(As of 10/4/2024 ET)

About LifeMD Stock (NASDAQ:LFMD)

Key Stats

Today's Range
$4.71
$5.03
50-Day Range
$4.68
$7.13
52-Week Range
$4.58
$12.88
Volume
514,219 shs
Average Volume
763,930 shs
Market Capitalization
$201.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Buy

Company Overview

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeMD Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
47th Percentile Overall Score

LFMD MarketRank™: 

LifeMD scored higher than 47% of companies evaluated by MarketBeat, and ranked 627th out of 994 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    LifeMD has only been the subject of 3 research reports in the past 90 days.

  • Read more about LifeMD's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeMD are expected to grow in the coming year, from ($0.49) to $0.18 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeMD is -6.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeMD is -6.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    LifeMD has a P/B Ratio of 32.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about LifeMD's valuation and earnings.
  • Percentage of Shares Shorted

    13.79% of the float of LifeMD has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeMD has a short interest ratio ("days to cover") of 7.2.
  • Change versus previous month

    Short interest in LifeMD has recently decreased by 8.38%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    LifeMD does not currently pay a dividend.

  • Dividend Growth

    LifeMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.79% of the float of LifeMD has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeMD has a short interest ratio ("days to cover") of 7.2.
  • Change versus previous month

    Short interest in LifeMD has recently decreased by 8.38%, indicating that investor sentiment is improving significantly.
  • Search Interest

    Only 9 people have searched for LFMD on MarketBeat in the last 30 days. This is a decrease of -53% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeMD insiders have bought more of their company's stock than they have sold. Specifically, they have bought $14,790.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    18.89% of the stock of LifeMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 35.52% of the stock of LifeMD is held by institutions.

  • Read more about LifeMD's insider trading history.
Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

LFMD Stock News Headlines

Next opportunity for crypto millions
October isn't just another month in crypto. It's the launchpad for what could be the most explosive bull run in history. And I've found the rocket fuel… One coin is quietly positioning itself to outperform the entire market. The signs are everywhere…
LifeMD, Inc. (LFMD)
Strong Growth and Positive Outlook Justify Buy Rating for LifeMD
LifeMD Inc LFMD
See More Headlines

LFMD Stock Analysis - Frequently Asked Questions

LifeMD's stock was trading at $8.29 at the start of the year. Since then, LFMD shares have decreased by 41.7% and is now trading at $4.83.
View the best growth stocks for 2024 here
.

LifeMD, Inc. (NASDAQ:LFMD) posted its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.06. The company earned $50.66 million during the quarter, compared to analyst estimates of $48.47 million.

Top institutional shareholders of LifeMD include SG Americas Securities LLC (0.03%). Insiders that own company stock include Justin Schreiber, Bertrand Velge, Naveen Bhatia, Nicholas P Alvarez, Eric Harold Yecies, Stefan Galluppi, Joseph Ditrolio and Marc David Benathen.
View institutional ownership trends
.

Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
8/07/2024
Today
10/05/2024
Next Earnings (Estimated)
11/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
Healthcare
Current Symbol
NASDAQ:LFMD
Fax
N/A
Employees
230
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.00
High Stock Price Target
$15.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+148.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-20,600,000.00
Pretax Margin
-12.10%

Debt

Sales & Book Value

Annual Sales
$178.28 million
Book Value
$0.15 per share

Miscellaneous

Free Float
33,869,000
Market Cap
$201.69 million
Optionable
Optionable
Beta
1.18
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:LFMD) was last updated on 10/6/2024 by MarketBeat.com Staff
From Our Partners